Lantern Pharma Inc. SEC filings LTRN
Lantern Pharma Inc. has 262 filings in SEC EDGAR's recent list, going back to Jan 14, 2019. Its latest annual report, Form ARS, was filed on Oct 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Sep 30, 2026 | — |
| S-1 | Registration statement | Jun 12, 2026 | — |
| 424B5 | Prospectus supplement | May 14, 2026 | — |
| 424B5 | Prospectus supplement | Mar 30, 2026 | — |
| 424B5 | Prospectus supplement | Jul 3, 2025 | — |
| S-8 | Employee stock plan registration | May 24, 2024 | — |
| S-3 | Shelf registration | May 24, 2024 | — |
| S-3 | Shelf registration | Jul 2, 2021 | — |
| 424B4 | Prospectus | Jan 15, 2021 | — |
| S-1MEF | Registration statement | Jan 15, 2021 | — |
| FWP | Free writing prospectus | Jan 11, 2021 | — |
| S-1 | Registration statement | Jan 8, 2021 | — |
| 424B4 | Prospectus | Jun 12, 2020 | — |
| S-1MEF | Registration statement | Jun 12, 2020 | — |
| S-1/A | Amended registration statement | Jun 8, 2020 | — |
| FWP | Free writing prospectus | May 19, 2020 | — |
| S-1/A | Amended registration statement | May 19, 2020 | — |
| S-1/A | Amended registration statement | May 12, 2020 | — |
| S-1 | Registration statement | Apr 16, 2020 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LTRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1763950
- Former names
- Lantern Pharma (until Jan 14, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.